END CANCER ALLIANCE
END CANCER ALLIANCE
  • Home
  • Home (ES)
  • About Prostate Cancer
    • About Prostate Cancer
    • Sobre Cáncer de Próstata
  • Prevention
    • Prevention
    • Prevención
  • Stages & Treatments
    • Stages and Treatments
    • Etapas y Tratamientos
  • News & Research
    • News & Research
    • Noticias e Investigación
  • More
    • Home
    • Home (ES)
    • About Prostate Cancer
      • About Prostate Cancer
      • Sobre Cáncer de Próstata
    • Prevention
      • Prevention
      • Prevención
    • Stages & Treatments
      • Stages and Treatments
      • Etapas y Tratamientos
    • News & Research
      • News & Research
      • Noticias e Investigación
  • Home
  • Home (ES)
  • About Prostate Cancer
    • About Prostate Cancer
    • Sobre Cáncer de Próstata
  • Prevention
    • Prevention
    • Prevención
  • Stages & Treatments
    • Stages and Treatments
    • Etapas y Tratamientos
  • News & Research
    • News & Research
    • Noticias e Investigación

Upcoming prostate cancer awareness events you

5th UCSF/CPCC Patient Conference

5th UCSF/CPCC Patient Conference

5th UCSF/CPCC Patient Conference

 Co-hosted by the University of California, San Francisco (UCSF) and the California Prostate Cancer Coalition (CPCC), offers insights into the latest advancements in prostate cancer. 

see more

PSMA and Beyond Conference 2025

5th UCSF/CPCC Patient Conference

5th UCSF/CPCC Patient Conference

 Co-sponsored by UCLA, UCSF, and the Prostate Cancer Foundation (PCF), this conference focuses on PSMA PET imaging, radioligand therapy, and theranostics, featuring leading experts in the field. 

see more
Nanoparticles are tested as a means to deliver drugs to prostate cancer cells.

Credit: National Can

Latest Updates in Prostate Cancer Research

Genomic Testing Enhancements

Recent studies have focused on the development of genomic tests to better identify aggressive forms of prostate cancer. These tests aim to improve early detection and personalize treatment plans, potentially leading to better patient outcomes. 

Advances in Prostate Cancer Research

 NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat prostate cancer. 

Learn more

Your source for the latest research news

Immunotherapy Advancements

Research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. This approach tailors treatment to individual genetic profiles, enhancing efficacy. 

Inherited gene elevates prostate cancer risk in affected families

 The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new study. 

Learn more

PARP Inhibitors

Drugs such as olaparib, rucaparib, niraparib, and talazoparib have been approved for use alongside hormone therapy in treating advanced prostate cancers with specific DNA repair gene mutations.  

See news

For Support, please email us at  support@endcanceralliance.org or call +1 (925) 306-4404


You can send mail and/or donations to 1630 N Main St #229, Walnut Creek, CA 94596


Copyright © 2025 END PROSTATE CANCER ALLIANCE - All rights reserved



  • Home
  • Home (ES)
  • Privacy Policy
  • Privacy Policy (ES)

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept